First Trust Nasdaq Pharmaceuticals ETF · $1.2B$18,039
FTXHFTXH vsARKGARKGARK Genomic Revolution ETF · $2.2B$6,586
$10,000 five years ago, dividends reinvested · they hold 9.0% in common
FTXHMeasureARKG
Returns · dividends reinvested
+33.8%Year to dateJan 1 → Nov 3+70.9%
+46.6%1 yearTotal return+59.0%
+24.1%3 years · per year$10,000 became $19,115 · $22,262+30.6%
+12.5%5 years · per year$10,000 became $18,039 · $6,586−8.0%
Cost and income
0.60%Expense ratio$60 · $75 a year on $10k · lower is better0.75%
0.66%Trailing 12-mo yield$66 · $0 a year on $10k0.00%
Risk · past year
−7.5%Worst dropSmaller is better−27.5%
17.7%VolatilityLower is calmer45.8%
FTXHARKG Winner of the row, in its colourEach row: the bigger of the two fills its side
5–3FTXH wins
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns